The reducing ends of dextrans, of which number‐average molecular weights were 3600 and 16000, were almost quantitatively converted to lactone, amine, and acyllactam groups, successively, by iodine oxidation followed by lactonization, aminolysis with 1,4‐diaminobutane, and finally reaction with terephthaloylbis (ϵ‐caprolactam). Hydroxyl groups in dextrans were also trimethylsilylated for protection with a mixture of 1,1,1,3,3,3‐hexamethyldisilazane and trimethylchlorosilane. In advance of every run, the adequate reaction conditions were search by using D ‐maltose as a low molecular weight model compound for dextrans.
No takes yet. Share an insight, caveat, or question.
Hashimoto et al. (1991) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: